Eris Lifesciences Limited

Price Chart

Risk-Adjusted Performance

Eris Lifesciences Limited (ERIS) Price Performance

Eris Lifesciences Limited (ERIS) trades on NSE in INR. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at INR1445.50, down 1.36% from the previous close.

Over the past year, ERIS has traded between a low of INR1280.40 and a high of INR1801.70. The stock has lost 14.7% over this period. It is currently 19.8% below its 52-week high.

Eris Lifesciences Limited has a market capitalization of $203.03B, with a price-to-earnings ratio of 46.52.

About Eris Lifesciences Limited

Eris Lifesciences Limited, together with its subsidiaries, provides domestic branded formulations for chronic and sub-chronic therapies in India and internationally. The company offers various branded formulations in various therapeutic areas, such as anti"diabetes, cardiovascular, nutrition, dermatology, neuroscience, gynecology, nephrology, and oncology, as well as central nervous system, women's health, and vitamins/minerals/nutrients. It also provides patient care services, including ambulatory blood pressure measurement, ambulatory electrocardiogram measurement, continuous glucose monitoring system, sleep study, and anti-natal care solutions. It offers its products through wholesale drug distributors, stockists, retail and e-commerce pharmacies. Eris Lifesciences Limited was incorporated in 2007 and is headquartered in Ahmedabad, India.